Form D — CND Life Sciences, Inc.
0001841099-25-000003 · filed 2025-04-15
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $9,000,000
- Total sold
- $3,664,565
- Minimum investment
- $25,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- CND Life Sciences, Inc.
- CIK
- 1841099
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 9165 E. DEL CAMINO DRIVE
SCOTTSDALE, AZ 85258-4381 - Phone
- 617-223-1585
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Richard J. Morello · Executive OfficerAtlanta, GA Find on LinkedIn ↗
-
Todd Levine · Executive OfficerParadise Valley, AZ Find on LinkedIn ↗
-
Peter Harris · Executive OfficerBrookline, MA Find on LinkedIn ↗
-
Enrique Carrazana · DirectorCoral Gables, FL Find on LinkedIn ↗
-
Christopher Gibbons · DirectorBrookline, MA Find on LinkedIn ↗
-
Jack Seaver · DirectorNew York, NY Find on LinkedIn ↗
View original on SEC EDGAR.